Little is known about the metabolism of glucosylsphingosine, but several recent studies indicated that it may serve as a biomarker for Gaucher disease, a lysosomal storage disorder characterized by mutations in GBA (49, –, 51). Here, GBA1 is linked to lysosomal storage disease.